David Parra, PharmD, FCCP, BCPS

Clinical Associate Professor, College of Pharmacy

David Parra

Contact Info


Office Phone 561-422-7395

Fax 561-422-5787

Office Address:
7305 N. Military Trail, West Palm Beach, FL 33410-6400

Mailing Address:
7305 N. Military Trail, West Palm Beach, FL 33410-6400

Clinical Associate Professor, College of Pharmacy

Clinical Pharmacy Specialist, Cardiology

Residency, Cardiovascular Pharmacotherapy, University of Minnesota

Fellowship, Cardiovascular Pharmacotherapy, University of Minnesota

PharmD, University of Minnesota

Bachelor of Biology, Marquette University


My research has traditionally focused on questions or observations generated during my clinical practice allowing me to not only remain flexible and opportunistic in what I research, but to also generate findings that can be readily applied to clinical practice. This is my motivation to conduct research. In regards to educational activities I precept many pharmacy students and post-doctoral pharmacy residents. Students gain an impressive amount of knowledge during their didactic portion of pharmacy school, but often lack the skills to efficiently and expeditiously expand and apply the knowledge they have garnered. I view my four main teaching responsibilities are 1) to help students/residents learn how to learn, 2) to demonstrate that while difficult, this learning process can be enjoyable, 3) to promote effective verbal and written communication with patients, peers, and other health care providers, and 4) to guide the trainee in recognizing that the profession is one of continuous learning.

Awards & Recognition

  • Clinical Pharmacist of the Year-West Palm Beach Veterans Affairs Medical Center, 2010
  • University of Minnesota College of Pharmacy Institutional Preceptor of the Year, 2008
  • Special Contribution Award-Transplant Model of Care, Veterans Affairs Central Office, 2008
  • University of Minnesota PDX Distinguished Alumnus, 2007
  • Palm Beach Atlantic University College of Pharmacy-Distinguished Preceptor, 2007
  • Palm Beach Atlantic University College of Pharmacy -Honorary Alumnus, 2007
  • University of Minnesota College of Pharmacy Commencement Speaker, 2006
  • Clinical Pharmacist of the Year- West Palm Beach Veterans Affairs Medical Center, 2004


Research Summary/Interests

Research Interests

Identification and evaluation of potentially significant drug interactions with warfarin

  • Evaluation of formulary initiatives/conversions from an efficacy, safety and economic standpoint
  • Impact of clinical pharmacy specialists on cardiovascular risk factors
  • Use of biomarkers and/or non-invasive hemodynamics to guide antihypertensive therapy
  • Chronotherapy, blood pressure variability and 24 hour ambulatory blood pressure monitoring

Research Projects

Co-investigator on a Pilot Study to Determine the Effectiveness of Pharmacist-Provided Medication Therapy Management (MTM) Using Face-to-Face and TeleMTM in the Treatment of Long-haul Drivers with Hypertension Department of Transportation Classifications Stage 1, 2, and 3.


  • Olson N, DeJongh B, Hough A, Parra D. Plasma Renin Activity-Guided Strategy for the Management of Hypertension. Pharmacotherapy 2012;32(5):446-455.
  • Karimi S, Hough A, Beckey C, Parra D. Safety Initiative for Patients on Concomitant Amiodarone and Simvastatin Therapy. Journal of Managed Care Pharmacy 2010;16(7):472-81.
  • Segarra-Newnham, Parra D, Martin-Cooper E. Effectiveness and Hepatotoxicity of Statins in Men Seropositive for Hepatitis C Virus. Pharmacotherapy 2007;27(6):845-851.
  • Parra D, Beckey N, Stevens G. The Effect of Acetaminophen on the International Normalized Ratio (INR) in Patients Stabilized on Warfarin Therapy. Pharmacotherapy 2007;27(5):675-683.
  • Parra D, Beckey N, Raval H, Schnacky K, Calabrese V, Coakley R, Goodhope R. Effect of Splitting Simvastatin Tablets for Control of Low-Density Lipoprotein Cholesterol. American Journal of Cardiology 2005; 95(12): 1481-1483.
  • Parra D, Lundy A, Bierman B. Alpha-blocker Monotherapy and Anticipated Occurrences of Heart Failure in Hypertensive Veterans. American Journal of Hypertension 2005; 18(4):574-575.
  • Parra D, Legreid AM, Beckey NP, Reyes S. Metformin Monitoring and Change in Serum Creatinine in Patients Undergoing Radiologic Procedures Involving the Administration of Intravenous Contrast Media. Pharmacotherapy 2004;24(8):987-993. Erratum in: Pharmacotherapy 2004; Oct;24(10):1489.
  • Geber J, Parra D, Beckey NP, Korman L. Optimizing Drug Therapy in Patients with Cardiovascular Disease: The Impact of Pharmacist-Managed Pharmacotherapy Clinics in a Primary Care Setting. Pharmacotherapy 2002; 22(6):738-47.
  • Parra D, Beckey NP, Korman L. Retrospective Evaluation of the Conversion of Amlodipine to Alternative Calcium Channel Blockers. Pharmacotherapy 2000;20(9):1072-1078.
  • Beckey NP, Parra D, Colon A. Retrospective Evaluation of a Potential Interaction Between Azithromycin and Warfarin in Patients Stabilized on Warfarin Therapy. Pharmacotherapy 2000;20(9):1055-1059.
  • Beckey NP, Korman L, Parra D. Effect of the Moderate Consumption of Olestra in Patients Receiving Long-term Warfarin Therapy. Pharmacotherapy 1999;19(9):1075-1079


Board Certifications

  • Board Certified Pharmacotherapy Specialist

Clinical Interests

Heart failure; Hypertension; Atrial fibrillation; Non-invasive measurement of hemodynamics; 24 hour ambulatory blood pressure monitoring; Cardiovascular risk factor modification

Clinical Experience Statement

I approach the management of cardiovascular disease in any given patient with the intent of both preserving the autonomy of the patient while providing them with appropriate evidence based recommendations. My care focuses heavily not only on the provision evidence based pharmacotherapy, but also on assuring the patient has a clear understanding of what their medication regimen can and cannot provide, as well as their role in optimizing their cardiovascular health. I currently practice full-time